The Gender Impact on Morphogenetic Variability in Coronary Artery Disease: A Preliminary Study

Radmila Karan1,2, Biljana Obrenovic-Kircanski3,4, Suzana Cvjeticanin5,6

  • 1Faculty of Medicine, University of Belgrade, Koste Todorovic 8, Belgrade 11000, Serbia. karan.radmila@gmail.com.

Insights

Genetic analysis reveals increased homozygosity and reduced variability in coronary artery disease (CAD) patients compared to controls. This suggests a potential genetic predisposition for developing CAD in both males and females.

Area of Science:

  • Genetics
  • Cardiology
  • Human Physiology

Background:

  • Coronary artery disease (CAD) is a multifactorial condition influenced by genetic and environmental factors.
  • Understanding genetic predispositions can aid in risk stratification and prevention strategies.
  • Morphogenetic variability and homozygosity are potential indicators of genetic health and disease susceptibility.

Purpose of the Study:

  • To investigate the association between genetic homozygosity and coronary artery disease (CAD).
  • To compare the degree of recessive homozygosity and morphogenetic variability between CAD patients and healthy controls.
  • To explore potential gender-specific differences in these genetic markers in relation to CAD.

Main Methods:

  • Analyzed morphogenetic variability and homozygosity using the homozygously recessive characteristics (HRC) test in 235 CAD patients and 152 healthy controls.
  • Tested 19 specific HRCs to quantify the degree of recessive homozygosity.
  • Compared HRC frequencies between CAD patients (with and without diabetes mellitus or hypertension) and control groups, analyzing data separately for males and females.

Main Results:

  • CAD patients exhibited a significantly higher frequency of HRCs compared to controls in both males (p < 0.001) and females (p < 0.001).
  • This significant difference persisted when comparing controls to CAD patients with diabetes mellitus (DM) and hypertension (HTN).
  • No significant difference in HRC frequencies was observed between CAD with DM and CAD with HTN groups.

Conclusions:

  • Findings indicate an increased degree of recessive homozygosity and decreased variability in both genders of CAD patients.
  • This suggests a potential genetic predisposition contributing to the development of coronary artery disease.
  • Genetic factors, specifically homozygosity, may play a significant role in CAD susceptibility.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
516
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
733
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
391